Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X8JE
|
|||
Former ID |
DNC008496
|
|||
Drug Name |
N-(3-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide
|
|||
Synonyms |
CHEMBL404983
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H25NO3
|
|||
Canonical SMILES |
CCCCCCC1=CC(=C(C=C1)OC2=CC=CC(=C2)NC(=O)C)O
|
|||
InChI |
1S/C20H25NO3/c1-3-4-5-6-8-16-11-12-20(19(23)13-16)24-18-10-7-9-17(14-18)21-15(2)22/h7,9-14,23H,3-6,8H2,1-2H3,(H,21,22)
|
|||
InChIKey |
DCPQCSKZPKBKGX-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bacterial Fatty acid synthetase I (Bact inhA) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors. Bioorg Med Chem Lett. 2008 May 15;18(10):3029-33. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.